Comment on: “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal”

Odette Reifsnider, Fiona Hall, Sonja Sorensen (), Irina Proskorovsky, Isabelle Girod and Jennifer Lee
Additional contact information
Odette Reifsnider: Evidera
Fiona Hall: Janssen-Cilag Limited
Sonja Sorensen: Evidera
Irina Proskorovsky: Evidera
Isabelle Girod: Janssen-Cilag Limited
Jennifer Lee: Janssen-Cilag Limited

PharmacoEconomics, 2017, vol. 35, issue 6, No 6, 663 pages

Date: 2017
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40273-017-0502-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0502-8

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-017-0502-8

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().